Up to 4 million women in the UK with irregular periods should now be investigated for polyendocrine metabolic ovarian syndrome (PMOS), under new draft NICE guidance published today. Previously known as PCOS, the condition affects one in eight women and is linked to higher risks of type 2 diabetes, heart disease, sleep apnoea, and mental health issues — yet it remains "frequently underdiagnosed and inconsistently managed." NICE's draft recommends anyone over 10...